My Report

Drug and Pharmaceutical Biotechnology Practice Test 8


Correct Answer: 2 points | Wrong: -1 point
Grades: A* (100% score) | A (80%-99%) | B (60%-80%) | C (40%-60%) | D (0%-40%)
advertisement

1. Which of the following is not a symptom for Multiple sclerosis?

2. A doctor should specify why any drug was started, stopped or the dose changed.

3. Release of water-soluble drugs can be retarded by presenting it as ____________ suspension.

4. Larger particle size leads to ____________ dissolution.

5. The 2nd part of a prescription is prefaced by which of the following?

6. What are the characteristics of continuous release systems?

7. What do you write on the prescription when the dosage has to be taken as required?

8. What is the characteristic of dissolution controlled release systems?

9. How is beta interferon produced?

10. What do you understand by the term ‘manifestation’ related to diabetes?


 

Manish Bhojasia - Founder & CTO at Sanfoundry
Manish Bhojasia, a technology veteran with 20+ years @ Cisco & Wipro, is Founder and CTO at Sanfoundry. He lives in Bangalore, and focuses on development of Linux Kernel, SAN Technologies, Advanced C, Data Structures & Alogrithms. Stay connected with him at LinkedIn.

Subscribe to his free Masterclasses at Youtube & discussions at Telegram SanfoundryClasses.